Product Trademark Name and Safety Testing
Evaluate proposed pharmaceutical brand name clinician feedback data for look-alike, sound-alike similarities, and historical error challenges to prevent medication errors.
Reduce risks with proactive evaluations
Med Safety Board (MSB) provides the most comprehensive name and trademark reviews as a partner for global data analysis, insight and recommendations related to name safety and error prevention. As an Institute for Safe Medication Practice (ISMP) company, MSB is uniquely positioned to use data from name-simulation studies with healthcare practitioners, ISMP product name issue reports, phonetic and orthographic computer analysis (POCA) scores, and product characteristic comparisons. We identify potential risks early.
The Difference
Our thorough testing process identifies potential risks in your pharmaceutical product names, minimizing confusion and reducing the likelihood of medication errors. By proactively identifying and addressing potential risks, we help you build confidence that your product name will garner approval and will stand out for all the right reasons—setting the stage for long-term success in the market.
White Paper
A Call to Action: Pharmaceutical Manufacturers Must Ensure Injectable Medication Labels are Well-Differentiated to Prevent Patient Harm
Get in Touch
Let's start zeroing in on exactly how we can help.
More Ways We Help
Drug and Device Risk Assessments
Identify and mitigate risks early using expert-led assessments to ensure safer, market-ready drug and device products.
Learn More